Imricor Medical Systems, Inc. (ASX:IMR)

Market Cap	427.80M
Revenue (ttm)	1.55M
Net Income (ttm)	-47.98M
Shares Out	320.45M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	82,838
Average Volume	311,134
Open	1.375
Previous Close	1.335
Day's Range	1.325 - 1.375
52-Week Range	0.460 - 1.860
Beta	-0.34
RSI	49.08
Earnings Date	Aug 26, 2025

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to min...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IMR

Financial Performance

In 2024, Imricor Medical Systems's revenue was $959,424, an increase of 55.86% compared to the previous year's $615,568. Losses were -$29.69 million, 31.2% more than in 2023.

Financial numbers in USD